Hymenamide C

General Information


DRACP ID  DRACP02936

Peptide Name   Hymenamide C

Sequence  ELWPFGP

Sequence Length  7

UniProt ID  Not available

PubChem CID  145740401 

Origin  Hymeniacidon sp.

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=25 µM MTT assay 3 days 1
HCT 116 Colon carcinoma Carcinoma IC50=5 µM MTT assay 3 days 1
RAW 264.7 Mouse leukemia Leukemia IC50>50 µM MTT assay 3 days 2

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02936

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  NCB: Glu1<--->Pro7

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C43H56N8O10

Absent amino acids  ACDHIKMNQRSTVY

Common amino acids  P

Mass  95216

Pl  3.85

Basic residues  0

Acidic residues  1

Hydrophobic residues  3

Net charge  -1

Boman Index  436

Hydrophobicity  -20

Aliphatic Index  55.71

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  916.67

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Carteritins A and B, cyclic heptapeptides from the marine sponge Stylissa carteri

Doi 10.1016/j.tetlet.2016.02.031

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPN_18431

DRACP is developed by Dr.Zheng's team.